nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—Cystitis noninfective—Mesalazine—Crohn's disease	0.00596	0.00596	CcSEcCtD
Betaxolol—Cystitis—Mesalazine—Crohn's disease	0.00589	0.00589	CcSEcCtD
Betaxolol—Neuropathy—Mesalazine—Crohn's disease	0.00573	0.00573	CcSEcCtD
Betaxolol—Dry eye—Mesalazine—Crohn's disease	0.00564	0.00564	CcSEcCtD
Betaxolol—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00561	0.00561	CcSEcCtD
Betaxolol—Bladder pain—Mesalazine—Crohn's disease	0.00552	0.00552	CcSEcCtD
Betaxolol—Mouth ulceration—Mesalazine—Crohn's disease	0.00552	0.00552	CcSEcCtD
Betaxolol—Hypertonia—Mesalazine—Crohn's disease	0.00535	0.00535	CcSEcCtD
Betaxolol—Ear pain—Mesalazine—Crohn's disease	0.00519	0.00519	CcSEcCtD
Betaxolol—Lymphadenopathy—Mesalazine—Crohn's disease	0.00519	0.00519	CcSEcCtD
Betaxolol—Immune system disorder—Mercaptopurine—Crohn's disease	0.0051	0.0051	CcSEcCtD
Betaxolol—Hypothyroidism—Prednisone—Crohn's disease	0.00503	0.00503	CcSEcCtD
Betaxolol—Alopecia—Mercaptopurine—Crohn's disease	0.00499	0.00499	CcSEcCtD
Betaxolol—Disorientation—Mesalazine—Crohn's disease	0.00495	0.00495	CcSEcCtD
Betaxolol—Deafness—Mesalazine—Crohn's disease	0.00495	0.00495	CcSEcCtD
Betaxolol—Eczema—Mesalazine—Crohn's disease	0.00493	0.00493	CcSEcCtD
Betaxolol—Malnutrition—Mercaptopurine—Crohn's disease	0.00492	0.00492	CcSEcCtD
Betaxolol—Eye pain—Mesalazine—Crohn's disease	0.00491	0.00491	CcSEcCtD
Betaxolol—Libido decreased—Mesalazine—Crohn's disease	0.00478	0.00478	CcSEcCtD
Betaxolol—Increased appetite—Mesalazine—Crohn's disease	0.00472	0.00472	CcSEcCtD
Betaxolol—Renal impairment—Mesalazine—Crohn's disease	0.00466	0.00466	CcSEcCtD
Betaxolol—Thirst—Mesalazine—Crohn's disease	0.00466	0.00466	CcSEcCtD
Betaxolol—Arthritis—Mesalazine—Crohn's disease	0.00456	0.00456	CcSEcCtD
Betaxolol—Anaemia—Mercaptopurine—Crohn's disease	0.00454	0.00454	CcSEcCtD
Betaxolol—Lethargy—Mesalazine—Crohn's disease	0.00452	0.00452	CcSEcCtD
Betaxolol—Osteoarthritis—Mesalazine—Crohn's disease	0.00443	0.00443	CcSEcCtD
Betaxolol—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.0044	0.0044	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00438	0.00438	CcSEcCtD
Betaxolol—Affect lability—Mesalazine—Crohn's disease	0.00436	0.00436	CcSEcCtD
Betaxolol—Mood swings—Mesalazine—Crohn's disease	0.0042	0.0042	CcSEcCtD
Betaxolol—Arthralgia—Mercaptopurine—Crohn's disease	0.00419	0.00419	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00416	0.00416	CcSEcCtD
Betaxolol—Oedema—Mercaptopurine—Crohn's disease	0.00401	0.00401	CcSEcCtD
Betaxolol—Breast disorder—Mesalazine—Crohn's disease	0.004	0.004	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00399	0.00399	CcSEcCtD
Betaxolol—Cramp muscle—Mesalazine—Crohn's disease	0.00399	0.00399	CcSEcCtD
Betaxolol—Nasopharyngitis—Mesalazine—Crohn's disease	0.00396	0.00396	CcSEcCtD
Betaxolol—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00393	0.00393	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00391	0.00391	CcSEcCtD
Betaxolol—Skin disorder—Mercaptopurine—Crohn's disease	0.0039	0.0039	CcSEcCtD
Betaxolol—Asthma—Mesalazine—Crohn's disease	0.00383	0.00383	CcSEcCtD
Betaxolol—Influenza—Mesalazine—Crohn's disease	0.00383	0.00383	CcSEcCtD
Betaxolol—Dysphagia—Mesalazine—Crohn's disease	0.00383	0.00383	CcSEcCtD
Betaxolol—Anorexia—Mercaptopurine—Crohn's disease	0.00382	0.00382	CcSEcCtD
Betaxolol—Pneumonia—Azathioprine—Crohn's disease	0.00377	0.00377	CcSEcCtD
Betaxolol—Bronchospasm—Mesalazine—Crohn's disease	0.00377	0.00377	CcSEcCtD
Betaxolol—Infestation NOS—Azathioprine—Crohn's disease	0.00375	0.00375	CcSEcCtD
Betaxolol—Infestation—Azathioprine—Crohn's disease	0.00375	0.00375	CcSEcCtD
Betaxolol—Angina pectoris—Mesalazine—Crohn's disease	0.00373	0.00373	CcSEcCtD
Betaxolol—Bronchitis—Mesalazine—Crohn's disease	0.00368	0.00368	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00366	0.00366	CcSEcCtD
Betaxolol—Dysuria—Mesalazine—Crohn's disease	0.00358	0.00358	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00356	0.00356	CcSEcCtD
Betaxolol—Arthropathy—Prednisone—Crohn's disease	0.00355	0.00355	CcSEcCtD
Betaxolol—Agranulocytosis—Azathioprine—Crohn's disease	0.0035	0.0035	CcSEcCtD
Betaxolol—Decreased appetite—Mercaptopurine—Crohn's disease	0.00349	0.00349	CcSEcCtD
Betaxolol—Weight increased—Mesalazine—Crohn's disease	0.00349	0.00349	CcSEcCtD
Betaxolol—Weight decreased—Mesalazine—Crohn's disease	0.00346	0.00346	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00346	0.00346	CcSEcCtD
Betaxolol—Leukocytosis—Prednisone—Crohn's disease	0.00344	0.00344	CcSEcCtD
Betaxolol—Pneumonia—Mesalazine—Crohn's disease	0.00343	0.00343	CcSEcCtD
Betaxolol—Infestation—Mesalazine—Crohn's disease	0.00341	0.00341	CcSEcCtD
Betaxolol—Infestation NOS—Mesalazine—Crohn's disease	0.00341	0.00341	CcSEcCtD
Betaxolol—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00341	0.00341	CcSEcCtD
Betaxolol—Depression—Mesalazine—Crohn's disease	0.0034	0.0034	CcSEcCtD
Betaxolol—Cataract—Prednisone—Crohn's disease	0.00339	0.00339	CcSEcCtD
Betaxolol—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00335	0.00335	CcSEcCtD
Betaxolol—Stomatitis—Mesalazine—Crohn's disease	0.00333	0.00333	CcSEcCtD
Betaxolol—Conjunctivitis—Mesalazine—Crohn's disease	0.00332	0.00332	CcSEcCtD
Betaxolol—Sweating—Mesalazine—Crohn's disease	0.00327	0.00327	CcSEcCtD
Betaxolol—Epistaxis—Mesalazine—Crohn's disease	0.00322	0.00322	CcSEcCtD
Betaxolol—Sinusitis—Mesalazine—Crohn's disease	0.0032	0.0032	CcSEcCtD
Betaxolol—Agranulocytosis—Mesalazine—Crohn's disease	0.00319	0.00319	CcSEcCtD
Betaxolol—Body temperature increased—Mercaptopurine—Crohn's disease	0.00317	0.00317	CcSEcCtD
Betaxolol—Rhinitis—Mesalazine—Crohn's disease	0.00307	0.00307	CcSEcCtD
Betaxolol—Pharyngitis—Mesalazine—Crohn's disease	0.00304	0.00304	CcSEcCtD
Betaxolol—Immune system disorder—Azathioprine—Crohn's disease	0.00304	0.00304	CcSEcCtD
Betaxolol—Mediastinal disorder—Azathioprine—Crohn's disease	0.00303	0.00303	CcSEcCtD
Betaxolol—Neuropathy—Prednisone—Crohn's disease	0.00303	0.00303	CcSEcCtD
Betaxolol—Chills—Azathioprine—Crohn's disease	0.00302	0.00302	CcSEcCtD
Betaxolol—Arrhythmia—Azathioprine—Crohn's disease	0.00301	0.00301	CcSEcCtD
Betaxolol—Alopecia—Azathioprine—Crohn's disease	0.00297	0.00297	CcSEcCtD
Betaxolol—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00296	0.00296	CcSEcCtD
Betaxolol—Eye disorder—Mesalazine—Crohn's disease	0.00286	0.00286	CcSEcCtD
Betaxolol—Tinnitus—Mesalazine—Crohn's disease	0.00286	0.00286	CcSEcCtD
Betaxolol—Cardiac disorder—Mesalazine—Crohn's disease	0.00284	0.00284	CcSEcCtD
Betaxolol—Angiopathy—Mesalazine—Crohn's disease	0.00278	0.00278	CcSEcCtD
Betaxolol—Immune system disorder—Mesalazine—Crohn's disease	0.00277	0.00277	CcSEcCtD
Betaxolol—Mediastinal disorder—Mesalazine—Crohn's disease	0.00276	0.00276	CcSEcCtD
Betaxolol—Chills—Mesalazine—Crohn's disease	0.00275	0.00275	CcSEcCtD
Betaxolol—Diarrhoea—Mercaptopurine—Crohn's disease	0.00275	0.00275	CcSEcCtD
Betaxolol—Ill-defined disorder—Azathioprine—Crohn's disease	0.00272	0.00272	CcSEcCtD
Betaxolol—Alopecia—Mesalazine—Crohn's disease	0.00271	0.00271	CcSEcCtD
Betaxolol—Thrombophlebitis—Prednisone—Crohn's disease	0.00271	0.00271	CcSEcCtD
Betaxolol—Anaemia—Azathioprine—Crohn's disease	0.00271	0.00271	CcSEcCtD
Betaxolol—Diabetes mellitus—Prednisone—Crohn's disease	0.0027	0.0027	CcSEcCtD
Betaxolol—Mental disorder—Mesalazine—Crohn's disease	0.00269	0.00269	CcSEcCtD
Betaxolol—Erythema—Mesalazine—Crohn's disease	0.00267	0.00267	CcSEcCtD
Betaxolol—Malaise—Azathioprine—Crohn's disease	0.00264	0.00264	CcSEcCtD
Betaxolol—Vascular purpura—Prednisone—Crohn's disease	0.00262	0.00262	CcSEcCtD
Betaxolol—Tension—Mesalazine—Crohn's disease	0.00262	0.00262	CcSEcCtD
Betaxolol—Dysgeusia—Mesalazine—Crohn's disease	0.00261	0.00261	CcSEcCtD
Betaxolol—Nervousness—Mesalazine—Crohn's disease	0.00259	0.00259	CcSEcCtD
Betaxolol—Muscle spasms—Mesalazine—Crohn's disease	0.00257	0.00257	CcSEcCtD
Betaxolol—Vomiting—Mercaptopurine—Crohn's disease	0.00255	0.00255	CcSEcCtD
Betaxolol—Injury—Prednisone—Crohn's disease	0.00255	0.00255	CcSEcCtD
Betaxolol—Rash—Mercaptopurine—Crohn's disease	0.00253	0.00253	CcSEcCtD
Betaxolol—Dermatitis—Mercaptopurine—Crohn's disease	0.00253	0.00253	CcSEcCtD
Betaxolol—Vision blurred—Mesalazine—Crohn's disease	0.00251	0.00251	CcSEcCtD
Betaxolol—Tremor—Mesalazine—Crohn's disease	0.0025	0.0025	CcSEcCtD
Betaxolol—Amnesia—Prednisone—Crohn's disease	0.0025	0.0025	CcSEcCtD
Betaxolol—Increased appetite—Prednisone—Crohn's disease	0.0025	0.0025	CcSEcCtD
Betaxolol—Arthralgia—Azathioprine—Crohn's disease	0.00249	0.00249	CcSEcCtD
Betaxolol—Myalgia—Azathioprine—Crohn's disease	0.00249	0.00249	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00248	0.00248	CcSEcCtD
Betaxolol—Ill-defined disorder—Mesalazine—Crohn's disease	0.00248	0.00248	CcSEcCtD
Betaxolol—Anaemia—Mesalazine—Crohn's disease	0.00247	0.00247	CcSEcCtD
Betaxolol—Discomfort—Azathioprine—Crohn's disease	0.00246	0.00246	CcSEcCtD
Betaxolol—Purpura—Prednisone—Crohn's disease	0.00243	0.00243	CcSEcCtD
Betaxolol—Malaise—Mesalazine—Crohn's disease	0.00241	0.00241	CcSEcCtD
Betaxolol—Cardiac failure—Prednisone—Crohn's disease	0.0024	0.0024	CcSEcCtD
Betaxolol—Vertigo—Mesalazine—Crohn's disease	0.0024	0.0024	CcSEcCtD
Betaxolol—Syncope—Mesalazine—Crohn's disease	0.00239	0.00239	CcSEcCtD
Betaxolol—Lethargy—Prednisone—Crohn's disease	0.00239	0.00239	CcSEcCtD
Betaxolol—Nausea—Mercaptopurine—Crohn's disease	0.00238	0.00238	CcSEcCtD
Betaxolol—Infection—Azathioprine—Crohn's disease	0.00238	0.00238	CcSEcCtD
Betaxolol—Palpitations—Mesalazine—Crohn's disease	0.00236	0.00236	CcSEcCtD
Betaxolol—Loss of consciousness—Mesalazine—Crohn's disease	0.00235	0.00235	CcSEcCtD
Betaxolol—Osteoarthritis—Prednisone—Crohn's disease	0.00234	0.00234	CcSEcCtD
Betaxolol—Thrombocytopenia—Azathioprine—Crohn's disease	0.00234	0.00234	CcSEcCtD
Betaxolol—Cough—Mesalazine—Crohn's disease	0.00233	0.00233	CcSEcCtD
Betaxolol—Skin disorder—Azathioprine—Crohn's disease	0.00232	0.00232	CcSEcCtD
Betaxolol—Affect lability—Prednisone—Crohn's disease	0.00231	0.00231	CcSEcCtD
Betaxolol—Psychotic disorder—Prednisone—Crohn's disease	0.00229	0.00229	CcSEcCtD
Betaxolol—Arthralgia—Mesalazine—Crohn's disease	0.00227	0.00227	CcSEcCtD
Betaxolol—Myalgia—Mesalazine—Crohn's disease	0.00227	0.00227	CcSEcCtD
Betaxolol—Chest pain—Mesalazine—Crohn's disease	0.00227	0.00227	CcSEcCtD
Betaxolol—Anxiety—Mesalazine—Crohn's disease	0.00226	0.00226	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00226	0.00226	CcSEcCtD
Betaxolol—Discomfort—Mesalazine—Crohn's disease	0.00224	0.00224	CcSEcCtD
Betaxolol—Hypotension—Azathioprine—Crohn's disease	0.00223	0.00223	CcSEcCtD
Betaxolol—Dry mouth—Mesalazine—Crohn's disease	0.00222	0.00222	CcSEcCtD
Betaxolol—Mood swings—Prednisone—Crohn's disease	0.00222	0.00222	CcSEcCtD
Betaxolol—Confusional state—Mesalazine—Crohn's disease	0.0022	0.0022	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00218	0.00218	CcSEcCtD
Betaxolol—Oedema—Mesalazine—Crohn's disease	0.00218	0.00218	CcSEcCtD
Betaxolol—Infection—Mesalazine—Crohn's disease	0.00216	0.00216	CcSEcCtD
Betaxolol—Shock—Mesalazine—Crohn's disease	0.00214	0.00214	CcSEcCtD
Betaxolol—Nervous system disorder—Mesalazine—Crohn's disease	0.00214	0.00214	CcSEcCtD
Betaxolol—Hypokalaemia—Prednisone—Crohn's disease	0.00213	0.00213	CcSEcCtD
Betaxolol—Thrombocytopenia—Mesalazine—Crohn's disease	0.00213	0.00213	CcSEcCtD
Betaxolol—Tachycardia—Mesalazine—Crohn's disease	0.00213	0.00213	CcSEcCtD
Betaxolol—Skin disorder—Mesalazine—Crohn's disease	0.00212	0.00212	CcSEcCtD
Betaxolol—Hyperhidrosis—Mesalazine—Crohn's disease	0.00211	0.00211	CcSEcCtD
Betaxolol—Anorexia—Mesalazine—Crohn's disease	0.00208	0.00208	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.00207	0.00207	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00206	0.00206	CcSEcCtD
Betaxolol—Hypotension—Mesalazine—Crohn's disease	0.00204	0.00204	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00198	0.00198	CcSEcCtD
Betaxolol—Feeling abnormal—Azathioprine—Crohn's disease	0.00197	0.00197	CcSEcCtD
Betaxolol—Insomnia—Mesalazine—Crohn's disease	0.00197	0.00197	CcSEcCtD
Betaxolol—Paraesthesia—Mesalazine—Crohn's disease	0.00196	0.00196	CcSEcCtD
Betaxolol—Dyspnoea—Mesalazine—Crohn's disease	0.00194	0.00194	CcSEcCtD
Betaxolol—Dyspepsia—Mesalazine—Crohn's disease	0.00192	0.00192	CcSEcCtD
Betaxolol—Decreased appetite—Mesalazine—Crohn's disease	0.00189	0.00189	CcSEcCtD
Betaxolol—Body temperature increased—Azathioprine—Crohn's disease	0.00189	0.00189	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00188	0.00188	CcSEcCtD
Betaxolol—Fatigue—Mesalazine—Crohn's disease	0.00188	0.00188	CcSEcCtD
Betaxolol—Erectile dysfunction—Prednisone—Crohn's disease	0.00187	0.00187	CcSEcCtD
Betaxolol—Pain—Mesalazine—Crohn's disease	0.00186	0.00186	CcSEcCtD
Betaxolol—Constipation—Mesalazine—Crohn's disease	0.00186	0.00186	CcSEcCtD
Betaxolol—Weight increased—Prednisone—Crohn's disease	0.00184	0.00184	CcSEcCtD
Betaxolol—Weight decreased—Prednisone—Crohn's disease	0.00183	0.00183	CcSEcCtD
Betaxolol—Hyperglycaemia—Prednisone—Crohn's disease	0.00183	0.00183	CcSEcCtD
Betaxolol—Depression—Prednisone—Crohn's disease	0.0018	0.0018	CcSEcCtD
Betaxolol—Feeling abnormal—Mesalazine—Crohn's disease	0.00179	0.00179	CcSEcCtD
Betaxolol—Acute coronary syndrome—Prednisone—Crohn's disease	0.00178	0.00178	CcSEcCtD
Betaxolol—Neuropathy peripheral—Prednisone—Crohn's disease	0.00177	0.00177	CcSEcCtD
Betaxolol—Myocardial infarction—Prednisone—Crohn's disease	0.00177	0.00177	CcSEcCtD
Betaxolol—Hypersensitivity—Azathioprine—Crohn's disease	0.00176	0.00176	CcSEcCtD
Betaxolol—Urticaria—Mesalazine—Crohn's disease	0.00173	0.00173	CcSEcCtD
Betaxolol—Body temperature increased—Mesalazine—Crohn's disease	0.00172	0.00172	CcSEcCtD
Betaxolol—Bradycardia—Prednisone—Crohn's disease	0.00165	0.00165	CcSEcCtD
Betaxolol—Diarrhoea—Azathioprine—Crohn's disease	0.00164	0.00164	CcSEcCtD
Betaxolol—Hallucination—Prednisone—Crohn's disease	0.00161	0.00161	CcSEcCtD
Betaxolol—Hypersensitivity—Mesalazine—Crohn's disease	0.0016	0.0016	CcSEcCtD
Betaxolol—Dizziness—Azathioprine—Crohn's disease	0.00158	0.00158	CcSEcCtD
Betaxolol—Asthenia—Mesalazine—Crohn's disease	0.00156	0.00156	CcSEcCtD
Betaxolol—Pruritus—Mesalazine—Crohn's disease	0.00154	0.00154	CcSEcCtD
Betaxolol—Vomiting—Azathioprine—Crohn's disease	0.00152	0.00152	CcSEcCtD
Betaxolol—Eye disorder—Prednisone—Crohn's disease	0.00152	0.00152	CcSEcCtD
Betaxolol—Rash—Azathioprine—Crohn's disease	0.00151	0.00151	CcSEcCtD
Betaxolol—Dermatitis—Azathioprine—Crohn's disease	0.00151	0.00151	CcSEcCtD
Betaxolol—Flushing—Prednisone—Crohn's disease	0.00151	0.00151	CcSEcCtD
Betaxolol—Headache—Azathioprine—Crohn's disease	0.0015	0.0015	CcSEcCtD
Betaxolol—Diarrhoea—Mesalazine—Crohn's disease	0.00149	0.00149	CcSEcCtD
Betaxolol—Angiopathy—Prednisone—Crohn's disease	0.00147	0.00147	CcSEcCtD
Betaxolol—Immune system disorder—Prednisone—Crohn's disease	0.00146	0.00146	CcSEcCtD
Betaxolol—Arrhythmia—Prednisone—Crohn's disease	0.00145	0.00145	CcSEcCtD
Betaxolol—Dizziness—Mesalazine—Crohn's disease	0.00144	0.00144	CcSEcCtD
Betaxolol—Alopecia—Prednisone—Crohn's disease	0.00143	0.00143	CcSEcCtD
Betaxolol—Mental disorder—Prednisone—Crohn's disease	0.00142	0.00142	CcSEcCtD
Betaxolol—Nausea—Azathioprine—Crohn's disease	0.00142	0.00142	CcSEcCtD
Betaxolol—Erythema—Prednisone—Crohn's disease	0.00141	0.00141	CcSEcCtD
Betaxolol—Malnutrition—Prednisone—Crohn's disease	0.00141	0.00141	CcSEcCtD
Betaxolol—Vomiting—Mesalazine—Crohn's disease	0.00138	0.00138	CcSEcCtD
Betaxolol—Rash—Mesalazine—Crohn's disease	0.00137	0.00137	CcSEcCtD
Betaxolol—Dermatitis—Mesalazine—Crohn's disease	0.00137	0.00137	CcSEcCtD
Betaxolol—Headache—Mesalazine—Crohn's disease	0.00136	0.00136	CcSEcCtD
Betaxolol—Vision blurred—Prednisone—Crohn's disease	0.00133	0.00133	CcSEcCtD
Betaxolol—Ill-defined disorder—Prednisone—Crohn's disease	0.00131	0.00131	CcSEcCtD
Betaxolol—Anaemia—Prednisone—Crohn's disease	0.0013	0.0013	CcSEcCtD
Betaxolol—Nausea—Mesalazine—Crohn's disease	0.00129	0.00129	CcSEcCtD
Betaxolol—Malaise—Prednisone—Crohn's disease	0.00127	0.00127	CcSEcCtD
Betaxolol—Vertigo—Prednisone—Crohn's disease	0.00127	0.00127	CcSEcCtD
Betaxolol—Syncope—Prednisone—Crohn's disease	0.00127	0.00127	CcSEcCtD
Betaxolol—Loss of consciousness—Prednisone—Crohn's disease	0.00124	0.00124	CcSEcCtD
Betaxolol—Arthralgia—Prednisone—Crohn's disease	0.0012	0.0012	CcSEcCtD
Betaxolol—Myalgia—Prednisone—Crohn's disease	0.0012	0.0012	CcSEcCtD
Betaxolol—Anxiety—Prednisone—Crohn's disease	0.0012	0.0012	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00119	0.00119	CcSEcCtD
Betaxolol—Discomfort—Prednisone—Crohn's disease	0.00119	0.00119	CcSEcCtD
Betaxolol—Oedema—Prednisone—Crohn's disease	0.00115	0.00115	CcSEcCtD
Betaxolol—Infection—Prednisone—Crohn's disease	0.00114	0.00114	CcSEcCtD
Betaxolol—Shock—Prednisone—Crohn's disease	0.00113	0.00113	CcSEcCtD
Betaxolol—Nervous system disorder—Prednisone—Crohn's disease	0.00113	0.00113	CcSEcCtD
Betaxolol—Tachycardia—Prednisone—Crohn's disease	0.00112	0.00112	CcSEcCtD
Betaxolol—Skin disorder—Prednisone—Crohn's disease	0.00112	0.00112	CcSEcCtD
Betaxolol—Hyperhidrosis—Prednisone—Crohn's disease	0.00111	0.00111	CcSEcCtD
Betaxolol—Anorexia—Prednisone—Crohn's disease	0.0011	0.0011	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00105	0.00105	CcSEcCtD
Betaxolol—Insomnia—Prednisone—Crohn's disease	0.00104	0.00104	CcSEcCtD
Betaxolol—Paraesthesia—Prednisone—Crohn's disease	0.00103	0.00103	CcSEcCtD
Betaxolol—Dyspepsia—Prednisone—Crohn's disease	0.00101	0.00101	CcSEcCtD
Betaxolol—Decreased appetite—Prednisone—Crohn's disease	0.001	0.001	CcSEcCtD
Betaxolol—Fatigue—Prednisone—Crohn's disease	0.000993	0.000993	CcSEcCtD
Betaxolol—Constipation—Prednisone—Crohn's disease	0.000985	0.000985	CcSEcCtD
Betaxolol—Feeling abnormal—Prednisone—Crohn's disease	0.00095	0.00095	CcSEcCtD
Betaxolol—Urticaria—Prednisone—Crohn's disease	0.000915	0.000915	CcSEcCtD
Betaxolol—Body temperature increased—Prednisone—Crohn's disease	0.000911	0.000911	CcSEcCtD
Betaxolol—Hypersensitivity—Prednisone—Crohn's disease	0.000849	0.000849	CcSEcCtD
Betaxolol—Asthenia—Prednisone—Crohn's disease	0.000827	0.000827	CcSEcCtD
Betaxolol—Pruritus—Prednisone—Crohn's disease	0.000815	0.000815	CcSEcCtD
Betaxolol—Diarrhoea—Prednisone—Crohn's disease	0.000788	0.000788	CcSEcCtD
Betaxolol—Dizziness—Prednisone—Crohn's disease	0.000762	0.000762	CcSEcCtD
Betaxolol—Vomiting—Prednisone—Crohn's disease	0.000733	0.000733	CcSEcCtD
Betaxolol—Rash—Prednisone—Crohn's disease	0.000727	0.000727	CcSEcCtD
Betaxolol—Dermatitis—Prednisone—Crohn's disease	0.000726	0.000726	CcSEcCtD
Betaxolol—Headache—Prednisone—Crohn's disease	0.000722	0.000722	CcSEcCtD
Betaxolol—Nausea—Prednisone—Crohn's disease	0.000684	0.000684	CcSEcCtD
